Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug discovery
MedTech
Insilico Medicine aims to generate nearly $300M in Hong Kong IPO
The IPO filing wraps up a year that saw Insilico raise $110 million in venture capital and sign multiple R&D deals with global drugmakers.
Conor Hale
Dec 18, 2025 11:17am
MapLight brightens SandboxAQ with CNS deal
Dec 16, 2025 7:30am
Chai infuses AI drug discovery efforts with $130M series B
Dec 15, 2025 11:11am
Sanofi, GSK ink preclinical pacts in hunt for new antibodies
Dec 10, 2025 11:15am
Voyager sets sail on neuro research trek with Transition Bio
Nov 10, 2025 5:23pm
Lilly continues AI push, inking $100M-plus deal with Insilico
Nov 10, 2025 9:00am
